Your browser doesn't support javascript.
loading
SAA1 and metabolomic signatures predict hyperprogression with immunotherapy in pan cancers.
Wang, Xiaoqing; Zhang, Longshan; Liao, Liwei; Li, Nan; Tang, Tingxi; Sun, Jianda; Zhou, Zhenhua; Liu, Yang; Huang, Jihong; Wang, Yingqiao; Chen, Zekai; Zhang, Hanbin; Xiao, Ting; Tian, Yunming; Zheng, Xiuting; Yuan, Yi; Xiao, Linlin; Liu, Laiyu; Guan, Jian.
Afiliação
  • Wang X; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Zhang L; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Liao L; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Li N; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Tang T; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Sun J; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Zhou Z; Department of Radiation Oncology, Meizhou People's Hospital, Meizhou, China.
  • Liu Y; Department of Respiratory and Critical Care Medicine, Chronic Airways Diseases Laboratory, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Huang J; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
  • Wang Y; Department of Respiratory and Critical Care Medicine, Chronic Airways Diseases Laboratory, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Chen Z; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Zhang H; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Xiao T; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Tian Y; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Zheng X; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Yuan Y; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Xiao L; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Liu L; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Guan J; Department of Respiratory and Critical Care Medicine, Chronic Airways Diseases Laboratory, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Clin Transl Med ; 14(3): e1624, 2024 03.
Article em En | MEDLINE | ID: mdl-38468504
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Humans Idioma: En Revista: Clin Transl Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Humans Idioma: En Revista: Clin Transl Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China